All In MedTech

Device Trial Radar · NCT03805243

Evaluation of the Signals Electrophysiological Measured by Intelligent Textiles

Evaluation of the Signals électrophysiologiques Measured by Intelligent Textiles

Last checked: Nov 19, 2026Latest source record: Nov 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

1

Actual

Start

Nov 29, 2019

Primary completion

Dec 21, 2020

Study completion Dec 21, 2020

Sponsor

Lead sponsor
BioSerenityNot on our public-company list
Sponsor type
Industry
First posted
Jan 15, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

BioSerenity suggests developing innovative solutions, from intelligent clothes which can be used in a hospital environment or at home. These textiles allow, in particular, to measure the biophysiological signals while letting to the participant the freedom pursue its daily activities. BioSerenity has already developed two wearable wireless and portable medical devices: cardioskin with textile ECG electrods , and the Neuronaute with textile EEG, EMG electrods. The aim of the study is to test these sensors to optimize their signal to integrate them in future Bioserenity devices like a somnonaute to help diagnosis of sleep disorders, like uronaute to help diagnosis of urination disorders, like toconaute to help monitoring of pregnancy. Others CE-marked sensors developed by others manufacturers will be tested to choose those that will be integrated in the Bioserenity devices.

Conditions

  • Healthy

Interventions

  • test of sensors for somnonaute deviceDevice

    test of sensors

  • test of sensors for uronaute deviceDevice

    test of sensors

  • test of sensors for toconaute deviceDevice

    test of sensors

  • test of sensors for neuronaute deviceDevice

    test of sensors

  • test of sensors for cardioskin deviceDevice

    test of sensors

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensor quality validationTime frame: 24 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Institut Du Cerveau Et de La Moelle Epiniere

    Paris, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.